APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Irbesartan Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Irbesartan Tablets Market Outlook and Growth Opportunities 2026

Report ID 174004540420 December 2025190 pages

Choose your research edition.

Industry ResearchIrbesartan Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Irbesartan Tablets Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Irbesartan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irbesartan Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Irbesartan Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Irbesartan Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Irbesartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Irbesartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Irbesartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Irbesartan Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Irbesartan Tablets market include Zhuhai Rundu Pharmaceutica, Teva, Sanofi, Jiangsu Hengrui Medicine, Verdant Life Sciences, Taj Pharmaceuticals and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Irbesartan Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Irbesartan Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Irbesartan Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Irbesartan Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Irbesartan Tablets Segment by Company

Zhuhai Rundu Pharmaceutica

Teva

Sanofi

Jiangsu Hengrui Medicine

Verdant Life Sciences

Taj Pharmaceuticals

Apotex

Irbesartan Tablets Segment by Type

75 mg Tablets

300 mg Tablets

150 mg Tablets

Irbesartan Tablets Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Irbesartan Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Irbesartan Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Irbesartan Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Irbesartan Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Irbesartan Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irbesartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irbesartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irbesartan Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Irbesartan Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Irbesartan Tablets industry.

Chapter 3: Detailed analysis of Irbesartan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Irbesartan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Irbesartan Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Irbesartan Tablets Industry Trends Table 2. Irbesartan Tablets Industry Drivers Table 3. Irbesartan Tablets Industry Opportunities and Challenges Table 4. Irbesartan Tablets Industry Restraints Table 5. Global Irbesartan Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Irbesartan Tablets Revenue Share by Company (2021-2026) Table 7. Global Irbesartan Tablets Sales Volume by Company (kg) & (2021-2026) Table 8. Global Irbesartan Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Irbesartan Tablets Average Price (US$/g) of Company (2021-2026) Table 10. Global Irbesartan Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Irbesartan Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Irbesartan Tablets Company, Product Type & Application Table 13. Global Irbesartan Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Irbesartan Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 75 mg Tablets Table 18. Significant Companies of 300 mg Tablets Table 19. Significant Companies of 150 mg Tablets Table 20. Global Irbesartan Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Irbesartan Tablets Sales Volume by Type (2021-2026) & (kg) Table 22. Global Irbesartan Tablets Sales Volume by Type (2027-2032) & (kg) Table 23. Global Irbesartan Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Irbesartan Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Irbesartan Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Irbesartan Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Irbesartan Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Irbesartan Tablets Sales Value Share by Type (2021-2026) Table 29. Global Irbesartan Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Retail Pharmacies Table 33. Global Irbesartan Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Irbesartan Tablets Sales Volume by Application (2021-2026) & (kg) Table 35. Global Irbesartan Tablets Sales Volume by Application (2027-2032) & (kg) Table 36. Global Irbesartan Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Irbesartan Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Irbesartan Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Irbesartan Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Irbesartan Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Irbesartan Tablets Sales Value Share by Application (2021-2026) Table 42. Global Irbesartan Tablets Sales Value Share by Application (2027-2032) Table 43. Global Irbesartan Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Irbesartan Tablets Sales by Region (2021-2026) & (kg) Table 45. Global Irbesartan Tablets Sales Market Share by Region (2021-2026) Table 46. Global Irbesartan Tablets Sales by Region (2027-2032) & (kg) Table 47. Global Irbesartan Tablets Sales Market Share by Region (2027-2032) Table 48. Global Irbesartan Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Irbesartan Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Irbesartan Tablets Sales Value Share by Region (2021-2026) Table 51. Global Irbesartan Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Irbesartan Tablets Sales Value Share by Region (2027-2032) Table 53. Global Irbesartan Tablets Market Average Price (US$/g) by Region (2021-2026) Table 54. Global Irbesartan Tablets Market Average Price (US$/g) by Region (2027-2032) Table 55. Global Irbesartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Irbesartan Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Irbesartan Tablets Sales by Country (2021-2026) & (kg) Table 58. Global Irbesartan Tablets Sales Market Share by Country (2021-2026) Table 59. Global Irbesartan Tablets Sales by Country (2027-2032) & (kg) Table 60. Global Irbesartan Tablets Sales Market Share by Country (2027-2032) Table 61. Global Irbesartan Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Irbesartan Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Irbesartan Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Irbesartan Tablets Sales Value Market Share by Country (2027-2032) Table 65. Zhuhai Rundu Pharmaceutica Company Information Table 66. Zhuhai Rundu Pharmaceutica Business Overview Table 67. Zhuhai Rundu Pharmaceutica Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Zhuhai Rundu Pharmaceutica Irbesartan Tablets Product Portfolio Table 69. Zhuhai Rundu Pharmaceutica Recent Development Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Teva Irbesartan Tablets Product Portfolio Table 74. Teva Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Sanofi Irbesartan Tablets Product Portfolio Table 79. Sanofi Recent Development Table 80. Jiangsu Hengrui Medicine Company Information Table 81. Jiangsu Hengrui Medicine Business Overview Table 82. Jiangsu Hengrui Medicine Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Jiangsu Hengrui Medicine Irbesartan Tablets Product Portfolio Table 84. Jiangsu Hengrui Medicine Recent Development Table 85. Verdant Life Sciences Company Information Table 86. Verdant Life Sciences Business Overview Table 87. Verdant Life Sciences Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 88. Verdant Life Sciences Irbesartan Tablets Product Portfolio Table 89. Verdant Life Sciences Recent Development Table 90. Taj Pharmaceuticals Company Information Table 91. Taj Pharmaceuticals Business Overview Table 92. Taj Pharmaceuticals Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 93. Taj Pharmaceuticals Irbesartan Tablets Product Portfolio Table 94. Taj Pharmaceuticals Recent Development Table 95. Apotex Company Information Table 96. Apotex Business Overview Table 97. Apotex Irbesartan Tablets Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 98. Apotex Irbesartan Tablets Product Portfolio Table 99. Apotex Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Irbesartan Tablets Distributors List Table 103. Irbesartan Tablets Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Irbesartan Tablets Product Image Figure 2. Global Irbesartan Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Irbesartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Irbesartan Tablets Sales (2021-2032) & (kg) Figure 5. Global Irbesartan Tablets Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Irbesartan Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 75 mg Tablets Image Figure 10. 300 mg Tablets Image Figure 11. 150 mg Tablets Image Figure 12. Global Irbesartan Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Irbesartan Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Irbesartan Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Irbesartan Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Irbesartan Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Irbesartan Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Global Irbesartan Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Irbesartan Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Irbesartan Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Irbesartan Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Irbesartan Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Irbesartan Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Irbesartan Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Irbesartan Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Irbesartan Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Irbesartan Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Irbesartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Irbesartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Irbesartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Irbesartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Irbesartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Irbesartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Irbesartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Irbesartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Irbesartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Irbesartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Irbesartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Irbesartan Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Irbesartan Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 75 mg Tablets
  • 300 mg Tablets
  • 150 mg Tablets
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Zhuhai Rundu Pharmaceutica
  • Teva
  • Sanofi
  • Jiangsu Hengrui Medicine
  • Verdant Life Sciences
  • Taj Pharmaceuticals
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Irbesartan Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Irbesartan Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Irbesartan Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Irbesartan Tablets Market Dynamics
  1. 2.1 Irbesartan Tablets Industry Trends
  2. 2.2 Irbesartan Tablets Industry Drivers
  3. 2.3 Irbesartan Tablets Industry Opportunities and Challenges
  4. 2.4 Irbesartan Tablets Industry Restraints
3 Irbesartan Tablets Market by Company
  1. 3.1 Global Irbesartan Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Irbesartan Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Irbesartan Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Irbesartan Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Irbesartan Tablets Company Ranking (2024-2026)
  6. 3.6 Global Irbesartan Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Irbesartan Tablets Company Product Type and Application
  8. 3.8 Global Irbesartan Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Irbesartan Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Irbesartan Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Irbesartan Tablets Market by Type
  1. 4.1 Irbesartan Tablets Type Introduction
  2. 4.1.1 75 mg Tablets
  3. 4.1.2 300 mg Tablets
  4. 4.1.3 150 mg Tablets
  5. 4.2 Global Irbesartan Tablets Sales Volume by Type
  6. 4.2.1 Global Irbesartan Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Irbesartan Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Irbesartan Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Irbesartan Tablets Sales Value by Type
  10. 4.3.1 Global Irbesartan Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Irbesartan Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Irbesartan Tablets Sales Value Share by Type (2021-2032)
5 Irbesartan Tablets Market by Application
  1. 5.1 Irbesartan Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Irbesartan Tablets Sales Volume by Application
  6. 5.2.1 Global Irbesartan Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Irbesartan Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Irbesartan Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Irbesartan Tablets Sales Value by Application
  10. 5.3.1 Global Irbesartan Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Irbesartan Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Irbesartan Tablets Sales Value Share by Application (2021-2032)
6 Irbesartan Tablets Regional Sales and Value Analysis
  1. 6.1 Global Irbesartan Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Irbesartan Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Irbesartan Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Irbesartan Tablets Sales by Region (2027-2032)
  5. 6.3 Global Irbesartan Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Irbesartan Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Irbesartan Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Irbesartan Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Irbesartan Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Irbesartan Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Irbesartan Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Irbesartan Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Irbesartan Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Irbesartan Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Irbesartan Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Irbesartan Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Irbesartan Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Irbesartan Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Irbesartan Tablets Sales Value Share by Country, 2025 VS 2032
7 Irbesartan Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Irbesartan Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Irbesartan Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Irbesartan Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Irbesartan Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Irbesartan Tablets Sales by Country (2027-2032)
  6. 7.4 Global Irbesartan Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Irbesartan Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Irbesartan Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Irbesartan Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Irbesartan Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Irbesartan Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhuhai Rundu Pharmaceutica
  2. 8.1.1 Zhuhai Rundu Pharmaceutica Company Information
  3. 8.1.2 Zhuhai Rundu Pharmaceutica Business Overview
  4. 8.1.3 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Product Portfolio
  6. 8.1.5 Zhuhai Rundu Pharmaceutica Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Irbesartan Tablets Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Irbesartan Tablets Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Jiangsu Hengrui Medicine
  20. 8.4.1 Jiangsu Hengrui Medicine Company Information
  21. 8.4.2 Jiangsu Hengrui Medicine Business Overview
  22. 8.4.3 Jiangsu Hengrui Medicine Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Medicine Irbesartan Tablets Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Medicine Recent Developments
  25. 8.5 Verdant Life Sciences
  26. 8.5.1 Verdant Life Sciences Company Information
  27. 8.5.2 Verdant Life Sciences Business Overview
  28. 8.5.3 Verdant Life Sciences Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Verdant Life Sciences Irbesartan Tablets Product Portfolio
  30. 8.5.5 Verdant Life Sciences Recent Developments
  31. 8.6 Taj Pharmaceuticals
  32. 8.6.1 Taj Pharmaceuticals Company Information
  33. 8.6.2 Taj Pharmaceuticals Business Overview
  34. 8.6.3 Taj Pharmaceuticals Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharmaceuticals Irbesartan Tablets Product Portfolio
  36. 8.6.5 Taj Pharmaceuticals Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Irbesartan Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Irbesartan Tablets Product Portfolio
  42. 8.7.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Irbesartan Tablets Value Chain Analysis
  2. 9.1.1 Irbesartan Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Irbesartan Tablets Sales Mode & Process
  6. 9.2 Irbesartan Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Irbesartan Tablets Distributors
  9. 9.2.3 Irbesartan Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst